Tech Company Financing Transactions
RaNA Therapeutics Funding Round
RaNA Therapeutics secured a $12 million funding round on 12/31/2012. Investors included Atlas Venture and private investors.
Transaction Overview
Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Atlas Venture (Jean-François Formela)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Sidney St. 310
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
RaNA Therapeutics is a biotechnology company using its proprietary RNA upregulation platform to discover and develop highly selective epigenetic modulators of gene expression. RaNA's technology upregulates the expression of desirable genes that can prevent or treat disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronald Renaud
VP - Bus. Development
Brian Fenton
Browse more venture capital transactions:
Prev: 12/31/2012: FreeWheel venture capital transaction
Next: 12/31/2012: SmarterHQ venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs